Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Relationship between childhood trauma and social adaptation in a sample of young people attending an early intervention service for psychosis.
Ortega L, Montalvo I, Solé M, Creus M, Cabezas Á, Gutiérrez-Zotes A, Sánchez-Gistau V, Vilella E, Labad J. Ortega L, et al. Among authors: creus m. Rev Psiquiatr Salud Ment (Engl Ed). 2020 Jul-Sep;13(3):131-139. doi: 10.1016/j.rpsm.2020.05.001. Epub 2020 Jun 29. Rev Psiquiatr Salud Ment (Engl Ed). 2020. PMID: 32616469 English, Spanish.
Raloxifene as an Adjunctive Treatment for Postmenopausal Women With Schizophrenia: A 24-Week Double-Blind, Randomized, Parallel, Placebo-Controlled Trial.
Usall J, Huerta-Ramos E, Labad J, Cobo J, Núñez C, Creus M, Parés GG, Cuadras D, Franco J, Miquel E, Reyes JC, Roca M; RALOPSYCAT Group. Usall J, et al. Among authors: creus m. Schizophr Bull. 2016 Mar;42(2):309-17. doi: 10.1093/schbul/sbv149. Epub 2015 Nov 20. Schizophr Bull. 2016. PMID: 26591005 Free PMC article. Clinical Trial.
Pharmacogenetic study of the effects of raloxifene on negative symptoms of postmenopausal women with schizophrenia: A double-blind, randomized, placebo-controlled trial.
Labad J, Martorell L, Huerta-Ramos E, Cobo J, Vilella E, Rubio-Abadal E, Garcia-Pares G, Creus M, Núñez C, Ortega L, Miquel E; RALOPSYCAT Group; Usall J. Labad J, et al. Among authors: creus m. Eur Neuropsychopharmacol. 2016 Oct;26(10):1683-9. doi: 10.1016/j.euroneuro.2016.08.006. Epub 2016 Aug 18. Eur Neuropsychopharmacol. 2016. PMID: 27546373
Effects of raloxifene on cognition in postmenopausal women with schizophrenia: a 24-week double-blind, randomized, parallel, placebo-controlled trial.
Huerta-Ramos E, Labad J, Cobo J, Núñez C, Creus M, García-Parés G, Cuadras D, Franco J, Miquel E, Reyes JC, Marcó-García S; RALOPSYCAT Group; Usall J. Huerta-Ramos E, et al. Among authors: creus m. Eur Arch Psychiatry Clin Neurosci. 2020 Sep;270(6):729-737. doi: 10.1007/s00406-019-01079-w. Epub 2019 Nov 14. Eur Arch Psychiatry Clin Neurosci. 2020. PMID: 31728631 Clinical Trial.
126 results